Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Shenzhen Hepalink Pharmaceutical Says Sees FY Net Loss Attributable RMB924.0 MLN- RMB647.0 MLN

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    30/01/2024 12:27
    Jan 30 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * SEES FY NET LOSS ATTRIBUTABLE RMB924.0 MILLION- RMB647.0
MILLION
    * EXPECTED RESULT DUE TO FALL IN SELLING PRICES OF CRUDE
HEPARIN
AND HEPARIN API IN 4Q, AMONG OTHERS

Source text for Eikon:  ID:n11053696-1 
Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news